(Q35074229)

25651917

6 August 2017

title

PCA3 in prostate cancer and tumor aggressiveness detection on 407 high-risk patients: a National Cancer Institute experience (English)

1 reference

6 August 2017

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25651917%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Isabella Sperduti

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25651917%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Rocco Papalia

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25651917%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Michele Gallucci

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25651917%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Laura Conti

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25651917%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Salvatore Guaglianone

10

object named as

Salvatore Guaglianone

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25651917%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

5

Steno Sentinelli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25651917%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

1

Roberta Merola

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25651917%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

3

Anna Antenucci

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25651917%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

7

Chiara Mandoj

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25651917%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

11

Manuela Costantini

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25651917%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

Serena Masi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25651917%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Giulia Orlandi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25651917%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Giuseppe Cusumano

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25651917%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Giovanni Cigliana

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25651917%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Paolo Ascenzi

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25651917%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

language of work or name

1 reference

6 February 2015

1 reference

25651917

Journal of Experimental & Clinical Cancer Research

6 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25651917%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25651917%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25651917%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

1 June 2020

copyright license

start time

6 February 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Perioperative changes in pro and anticoagulant factors in prostate cancer patients undergoing laparoscopic and robotic radical prostatectomy with different anaesthetic techniques

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324853

The PCA3 test for guiding repeat biopsy of prostate cancer and its cut-off score: a systematic review and meta-analysis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324853

PCA3 in the detection and management of early prostate cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324853

PCA3 molecular urine test as a predictor of repeat prostate biopsy outcome in men with previous negative biopsies: a prospective multicenter clinical study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324853

8 July 2018

Cancer statistics, 2013

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324853

Human periprostatic adipose tissue promotes prostate cancer aggressiveness in vitro.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324853

The value of urinary prostate cancer gene 3 (PCA3) scores in predicting pathological features at radical prostatectomy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324853

Prostatic intraepithelial neoplasia: its morphological and molecular diagnosis and clinical significance

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324853

The relationship between Prostate CAncer gene 3 (PCA3) and prostate cancer significance

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324853

Contemporary role of prostate cancer antigen 3 in the management of prostate cancer.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324853

Screening for prostate cancer with PSA testing: current status and future directions.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324853

Impact of comorbidity on survival among men with localized prostate cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324853

PCA3 molecular urine assay for prostate cancer: association with pathologic features and impact of collection protocols

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324853

PCA3: from basic molecular science to the clinical lab.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324853

EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324853

Critical assessment of preoperative urinary prostate cancer antigen 3 on the accuracy of prostate cancer staging.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324853

Other biomarkers for detecting prostate cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324853

Urinary estrogen metabolites and prostate cancer: a case-control study and meta-analysis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324853

Predictive value of PCA3 in urinary sediments in determining clinico-pathological characteristics of prostate cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324853

Screening and prostate-cancer mortality in a randomized European study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324853

Mortality results from a randomized prostate-cancer screening trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324853

Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324853

PCA3 molecular urine assay correlates with prostate cancer tumor volume: implication in selecting candidates for active surveillance

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324853

Prostate-specific antigen levels as a predictor of lethal prostate cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324853

The time-resolved fluorescence-based PCA3 test on urinary sediments after digital rectal examination; a Dutch multicenter validation of the diagnostic performance

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324853

Current status of transrectal ultrasound-guided prostate biopsy in the diagnosis of prostate cancer.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324853

Prostate biopsy: indications and technique

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324853

DD3: a new prostate-specific gene, highly overexpressed in prostate cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324853

Use of PCA3 in detecting prostate cancer in initial and repeat prostate biopsy patients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324853

DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer

27 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2FS13046-015-0127-8

Behavior of the PCA3 gene in the urine of men with high grade prostatic intraepithelial neoplasia

21 January 2018

1 reference

12 December 2020

Re: Hessels D, Klein Gunnewiek JMT, van Oort I, Karthaus HFM, van Leenders GJL, van Balken B, Kiemeney LA, Witjes JA, Schalken JA. DD3PCA3-based molecular urine analysis for the diagnosis of prostate cancer. Eur Urol 2003;44:8?16

1 reference

12 December 2020

Prostate cancer: surgery versus observation for localized prostate cancer

1 reference

12 December 2020

Prostate cancer gene 3 urine assay cutoff in diagnosis of prostate cancer: a validation study on an Italian patient population undergoing first and repeat biopsy

1 reference

12 December 2020

10.1186/S13046-015-0127-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25651917%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

1 June 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25651917%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

25651917

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25651917%20AND%20SRC:MED&resulttype=core&format=json